Fungal-free survival. Probability of survival without a proven or probable invasive fungal infection is shown for (A) all 294 people who received at least one dose of fluconazole or itraconazole during the course of the study, (B) 209 people who received study drug before the change in timing of drug administration, and (C) 90 people who received study drug after the change in study drug administration.